HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antonio E Lacerda Selected Research

vanoxerine (I 893)

11/2011Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results.
3/2010Vanoxerine, a new drug for terminating atrial fibrillation and flutter.
3/2010Vanoxerine: cellular mechanism of a new antiarrhythmic.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antonio E Lacerda Research Topics

Disease

3Atrial Fibrillation
11/2011 - 03/2010
2Pericarditis
11/2011 - 03/2010
2Atrial Flutter (Flutter, Atrial)
11/2011 - 03/2010
1Fibrosis (Cirrhosis)
12/2017
1Tachycardia (Tachyarrhythmias)
11/2011
1Cardiovascular Diseases (Cardiovascular Disease)
03/2010

Drug/Important Bio-Agent (IBA)

3vanoxerine (I 893)IBA
11/2011 - 03/2010
2Pharmaceutical PreparationsIBA
03/2010 - 03/2010
1Cysteamine (Mercaptamine)FDA Link
12/2017
1Fatty Acids (Saturated Fatty Acids)IBA
12/2017
1Potassium Channels (Potassium Channel)IBA
03/2010
1Amiodarone (Amiodarona)FDA LinkGeneric
03/2010
1Anti-Arrhythmia AgentsIBA
03/2010